Robin Chatterjee

Founder at EnginZyme AB

Health Technology

Profile

Robin Chatterjee has held the title of Commercial Director at EnginZyme AB since 2014.
He is also the founder of EnginZyme AB, which was founded in 2014.

Robin Chatterjee active positions

Companies	Position	Start
EnginZyme AB EnginZyme AB BiotechnologyHealth Technology EnginZyme AB is a Swedish company founded in 2014 by Samuel HÃ¤rgestam, Robin Chatterjee, and Karim Engelmark Cassimjee. EnginZyme is based in Stockholm, Sweden, and has a multidisciplinary team of experts in biocatalysis, organic chemistry, enzyme and process engineering, as well as AI and machine learning. The company has developed a patented, cell-free biomanufacturing platform that combines the power of biology with the efficiencies of the chemical industry. EnginZyme aims to produce better, greener, and more affordable products sustainably. The company's enzyme immobilisation technology enables biomanufacturing without living organisms, resulting in lower costs and a smaller environmental footprint. The company has been recognized as a technology pioneer by the World Economic Forum and was selected for the Cleantech 100 list in 2022 and 2023. Karim Engelmark Cassimjee has been the CEO since 2014.	Founder	2013-12-31

All active positions of Robin Chatterjee

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Robin Chatterjee's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
EnginZyme AB EnginZyme AB BiotechnologyHealth Technology EnginZyme AB is a Swedish company founded in 2014 by Samuel HÃ¤rgestam, Robin Chatterjee, and Karim Engelmark Cassimjee. EnginZyme is based in Stockholm, Sweden, and has a multidisciplinary team of experts in biocatalysis, organic chemistry, enzyme and process engineering, as well as AI and machine learning. The company has developed a patented, cell-free biomanufacturing platform that combines the power of biology with the efficiencies of the chemical industry. EnginZyme aims to produce better, greener, and more affordable products sustainably. The company's enzyme immobilisation technology enables biomanufacturing without living organisms, resulting in lower costs and a smaller environmental footprint. The company has been recognized as a technology pioneer by the World Economic Forum and was selected for the Cleantech 100 list in 2022 and 2023. Karim Engelmark Cassimjee has been the CEO since 2014.	Health Technology